Reference Electrophiles for Nucleophilicity Scales
5.36 (s, 1 H, OHarom.), 5.79 (s, 1 H), 6.70 (d, J = 8.8 Hz, 2 H), 60.8 mg, 0.51 mmol): 1H NMR (CDCl3, 300 MHz): δ = 5.44 (br. s,
7.24–7.56 (m, 14 H, Harom.) ppm. 13C NMR (CDCl3, 75.5 MHz): 1 H, OH), 6.16 (s, 1 H), 7.23–7.55 (m, 17 H, Harom.) ppm. 13C
δ = 40.6 (q, NMe2), 75.7 (d), 112.5 (d), 127.5 (d), 127.6 (d), 128.0 NMR (CDCl3, 75.5 MHz): δ = 64.2 (d), 127.6 (d), 127.9 (d), 128.0
(d), 128.5 (s), 128.8 (d), 129.3 (d), 132.0 (s), 136.6 (s), 137.6 (s), (d), 128.6 (d), 128.8 (s), 128.9 (d), 129.29 (d), 129.34 (d), 133.5 (s),
148.4 (s), 150.1 (s) ppm.
137.1 (s), 141.0 (s), 149.1 (s) ppm.
(4-Hydroxy-3,5-diphenylphenyl)(phenyl)methanol (5c): From bro-
mobenzene (2.02 mL, 3.01 g, 19.2 mmol) and 4-hydroxy-3,5-di-
phenylbenzaldehyde 4a (2.19 g, 8.00 mmol): 2.06 g (73%); colorless
solid; m.p. 147–149 °C (from Et2O/n-pentane). H NMR (CDCl3,
300 MHz): δ = 2.28 (d, J = 3.1 Hz, 1 H, CHOH), 5.41 (s, 1 H,
(4-Hydroxy-3,5-dimethoxyphenyl)(4-methoxyphenyl)methyl Chlo-
ride (6d): From 5d (1.00 g, 3.46 mmol) in CH2Cl2 (40 mL) and
SOCl2 (303 µL, 493 mg, 4.15 mmol): 1H NMR (CDCl3, 300 MHz):
δ = 3.81 (s, 3 H, OMe), 3.86 (s, 6 H, 2ϫOMe), 5.53 (br. s, 1 H,
OH), 6.08 (s, 1 H), 6.64 (s, 2 H), 6.87 (d, J = 8.7 Hz, 2 H), 7.32 (d,
J = 8.7 Hz, 2 H) ppm. 13C NMR (CDCl3, 75.5 MHz): δ = 55.3 (q,
OMe), 56.4 (q, 2ϫOMe), 64.8 (d), 104.8 (d), 113.8 (d), 129.0 (d),
132.3 (s), 133.4 (s), 134.5 (s), 146.8 (s), 159.3 (s) ppm.
1
OHarom.), 5.80 (d, J = 2.8 Hz, 1 H), 7.20–7.54 (m, 17 H, Harom.
)
ppm. 13C NMR (CDCl3, 75.5 MHz): δ = 75.9 (d), 126.4 (d), 127.5
(d), 127.7 (d), 128.2 (d), 128.5 (d), 128.7 (s), 128.8 (d), 129.3 (d),
136.2 (s), 137.4 (s), 143.8 (s), 148.8 (s) ppm.
Quinone Methides 3a,c,d: Under an atmosphere of dry N2, the
benzhydryl chloride 6 was dissolved in dry CH2Cl2 and 1.2–
1.3 equiv. of NEt3 were added. After stirring for 2 h, diethyl ether
or n-pentane was added. The resulting precipitate was filtered off
and dried under reduced pressure.
(4-Hydroxy-3,5-dimethoxyphenyl)(4-methoxyphenyl)methanol (5d):
From 4-bromoanisole (2.41 mL, 3.59 g, 19.2 mmol) and 4-hydroxy-
3,5-dimethoxybenzaldehyde 4b (1.46 g, 8.00 mmol): 1.92 g (83%);
colorless solid. 1H NMR (CDCl3, 300 MHz): δ = 2.14 (d, 3J =
3.5 Hz, 1 H, CHOH), 3.82 (s, 3 H, OMe), 3.88 (s, 6 H, 2ϫOMe),
5.48 (s, 1 H, OHarom.), 5.76 (d, 3J = 3.3 Hz, 1 H), 6.62 (s, 2 H),
6.89 (d, J = 9 Hz, 2 H), 7.30 (d, J = 9 Hz, 2 H) ppm. 13C NMR
(CDCl3, 75.5 MHz): δ = 55.3 (q, OMe), 56.3 (q, 2 OMe), 75.9 (d),
103.3 (d), 113.8 (d), 127.8 (d), 134.0 (s), 135.2 (s), 136.1 (s), 147.0
(s), 159.1 (s) ppm.
2,6-Diphenyl-4-(4-methoxybenzylidene)cyclohexa-2,5-dienone (3a):
From 6a (313 mg, 780 µmol) in CH2Cl2 (10 mL) and NEt3 (141 µL,
103 mg, 1.01 mmol): 199 mg (70%); yellow solid; m.p. 125–126 °C
(from Et2O). 1H NMR (CD2Cl2, 400 MHz): δ = 3.87 (s, 3 H, OMe),
7.02 (d, J = 8.8 Hz, 2 H), 7.35–7.47 (m, 8 H, Harom.), 7.55–7.63 (m,
6 H, Harom.), 7.93 (dd, J = 2.6, J = 0.6 Hz, 1 H) ppm. 13C NMR
(CD2Cl2, 101 MHz): δ = 55.6 (q, OMe), 114.7 (d), 127.8 (d), 127.9
(d), 128.01 (d), 128.02 (d), 128.3 (s), 129.3 (d), 129.4 (d), 130.1 (s),
132.5 (d), 133.0 (d), 137.1 (s), 137.5 (s), 138.3 (s), 140.2 (d), 146.6
(d), 161.7 (s), 183.5 (s, C=O) ppm. MS (EI): m/z (%) = 366 (16),
365 (18), 364 (64) [M+], 363 (100). HRMS (EI): calcd. for C26H20O2
364.1463; found 364.1465.
(4-Hydroxy-3,5-dimethoxyphenyl)[4-(dimethylamino)phenyl]meth-
anol (5e): From 4-bromo-N,N-dimethylaniline (4.80 g, 24.0 mmol)
and 4-hydroxy-3,5-dimethoxybenzaldehyde 4b (1.82 g, 10.0 mmol):
1
1.29 g (43%); light purple solid. H NMR (CDCl3, 300 MHz): δ =
3
2.07 (d, J = 3.5 Hz, 1 H, CHOH), 2.94 (s, 6 H, NMe2), 3.86 (s, 6
H, 2ϫOMe), 5.45 (s, 1 H, OHarom.), 5.70 (d, 3J = 3.4 Hz, 1 H),
6.63 (s, 2 H), 6.70 (d, J = 8.8 Hz, 2 H), 7.21 (d, J = 8.8 Hz, 2 H)
ppm. 13C NMR (CDCl3, 75.5 MHz): δ = 40.6 (q, NMe2), 56.3 (q,
OMe), 76.0 (d), 103.2 (d), 112.4 (d), 127.7 (d), 131.9 (s), 133.8 (s),
135.5 (s), 146.9 (s), 150.2 (s) ppm.
2,6-Diphenyl-4-benzylidenecyclohexa-2,5-dienone (3c): From 6c
(530 mg, 1.58 mmol) in CH2Cl2 (8 mL) and NEt3 (286 µL, 210 mg,
2.06 mmol): 386 mg (71%); yellow crystals; m.p. 170–172 °C (from
CH2Cl2/n-pentane). 1H NMR (CDCl3, 300 MHz): δ = 7.35–7.61
(m, 17 H, Harom.), 7.86 (dd, J = 2.6, J = 0.6 Hz, 1 H) ppm. 13C
NMR (CDCl3, 75.5 MHz): δ = 127.97 (d), 128.02 (d), 128.04 (d),
128.07 (d), 129.0 (d), 129.2 (d), 129.3 (d), 129.9 (d), 130.7 (d), 131.8
(s), 132.5 (d), 135.4 (s), 136.3 (s), 136.7 (s), 138.9 (s), 139.7 (d),
140.6 (s), 146.0 (d), 183.8 (s, C=O) ppm. MS (EI): m/z (%) = 335
(22), 334 (100) [M+], 333 (70), 256 (22). HRMS (EI): calcd. for
C25H18O 334.1358; found 334.1355.
(4-Hydroxy-3,5-dimethylphenyl)[4-(dimethylamino)phenyl]methanol
(5f): From 4-bromo-N,N-dimethylaniline (4.80 g, 24.0 mmol) and
4-hydroxy-3,5-dimethylbenzaldehyde 4c (1.50 g, 10.0 mmol): 1.88 g
(69%); light purple solid. 1H NMR ([D6]DMSO, 400 MHz): δ =
2.12 (s, 6 H, 2ϫMe), 2.83 (s, 6 H, NMe2), 5.33 (d, J = 4.0 Hz, 1
H), 5.42 (d, J = 4.0 Hz, 1 H), 6.64 (d, J = 8.8 Hz, 1 H), 6.84 (s, 2
H), 7.11 (d, J = 8.8 Hz, 1 H), 7.98 (s, 1 H, OHarom.) ppm. 13C
NMR ([D6]DMSO, 101 MHz): δ = 16.7 (q, Me), 40.3 (q, NMe2),
73.8 (d), 112.1 (d), 123.4 (s), 126.1 (d), 126.9 (d), 134.2 (s), 136.9
(s), 149.3 (s), 151.6 (s) ppm.
2,6-Dimethoxy-4-(4-methoxybenzylidene)cyclohexa-2,5-dienone
(3d): From 6d (1.07 g, 3.46 mmol) in CH2Cl2 (25 mL) and NEt3
(576 µL, 420 mg, 4.15 mmol): 584 mg (62%); yellow crystals; m.p.
178–180 °C (from CH2Cl2/n-pentane). 1H NMR (CD2Cl2,
400 MHz): δ = 3.78 (s, 3 H, OMe), 3.80 (s, 3 H, OMe), 3.86 (s, 3
H, OMe), 6.43 (s, 1 H), 6.91 (s, 1 H), 7.00 (d, J = 8.8 Hz, 2 H),
7.12 (s, 1 H), 7.48 (d, J = 8.6 Hz, 2 H) ppm. 13C NMR (CD2Cl2,
101 MHz): δ = 55.5 (q, OMe), 55.56, 55.57 (2q, 2 OMe), 105.7 (d),
113.1 (d), 114.5 (d), 128.7 (s), 129.0 (s), 132.0 (d), 140.7 (d), 152.1
(s), 153.7 (s), 160.6 (s), 174.8 (s, C=O) ppm. MS (EI): m/z (%) =
273 (20), 272 (100) [M+], 271 (19), 254 (17), 243 (41), 242 (30), 241
(16), 226 (28), 211 (22), 196 (15), 171 (16), 169 (18), 143 (22), 128
(20), 115 (53). HRMS (EI): calcd. for C16H16O4 272.1049; found
272.1052. C16H16O4 (272.30): calcd. C 70.57, H 5.92; found C
70.35, H 5.86.
Benzhydryl Chlorides 6a,c,d: Under an atmosphere of dry N2,
SOCl2 (1.2 equiv.) in dry CH2Cl2 (≈ 5 mL) was added dropwise to
a solution of the 4-hydroxybenzhydrol (1 equiv.) in dry CH2Cl2 at
0 °C. After stirring at this temperature for 2 h, the solvent was re-
moved under reduced pressure. Because the products were formed
nearly quantitatively, they were used for the following step without
further purification.
(4-Hydroxy-3,5-diphenylphenyl)(4-methoxyphenyl)methyl Chloride
(6a): From 5a (500 mg, 1.31 mmol) in CH2Cl2 (18 mL) and SOCl2
(115 µL, 187 mg, 1.57 mmol): 1H NMR (CDCl3, 300 MHz): δ =
3.80 (s, 3 H, OMe), 5.44 (s, 1 H, OH), 6.16 (s, 1 H), 6.87 (d, J =
8.8 Hz, 2 H), 7.32–7.57 (m, 14 H, Harom.) ppm. 13C NMR (CDCl3,
75.5 MHz): δ = 55.3 (q, OMe), 64.2 (d), 113.9 (d), 127.9 (d), 128.8
(d), 128.9 (d), 129.0 (d), 129.3 (d), 129.8 (s), 133.4 (s), 133.7 (s),
137.1 (s), 149.1 (s), 159.3 (s) ppm.
Quinone Methides 3e,f: Under an atmosphere of dry N2, the 4-
hydroxybenzhydrol (1 equiv.) was dissolved in dry CH2Cl2 and
cooled to 0 °C. Then ethereal HBF4 solution (1.1 equiv.) was added
at 0 °C. After 5 min, NEt3 (1.3 equiv.) was added. Stirring at room
temperature was continued for 3 h before the mixture was extracted
(4-Hydroxy-3,5-diphenylphenyl)(phenyl)methyl Chloride (6c): From
5c (150 mg, 0.43 mmol) in CH2Cl2 (6 mL) and SOCl2 (37 µL,
Eur. J. Org. Chem. 2009, 3203–3211
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3209